Evidence to Action Official Journal of MDCalc
Clonal Hematopoiesis Risk Score
By Austin Wesevich.
Abstract
The Clonal Hematopoiesis Risk Score (CHRS) stratifies patients with clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenia of undetermined significance (CCUS) into three different risk categories: low-risk (88.4%), intermediate-risk (10.5%), and high-risk (1.1%). These risk categories correspond to 10-year cumulative incidence of myeloid neoplasm of 0.7%, 7.8%, and 52.2%.
Keywords
- Acute Myeloid Leukemia Research
- clonal hematopoiesis of indeterminate potential
- clonal cytopenia of undetermined significance
- risk stratification
- cumulative incidence
- somatic mutations
- Open access
Source
Published in Evidence to Action Official Journal of MDCalc. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.